More recently, a clinical study demonstrated expression of IL-19 and IL-24 at the gene and protein expression levels in tissue and peripheral cells of patients exhibiting active or inactive Crohn’s Disease (CD) or active or inactive ulcerative colitis (UC) [55]. This evidence concerns the gene IL19 and Crohn disease.